Related Experiment Video
Updated: Jul 11, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Modulators of neuronal cell death in epilepsy
David C Henshall1, Brona M Murphy
1Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2, Ireland. dhenshall@rcsi.ie
Certain seizures damage brain, leading to neuronal loss and cognitive impairments. Manipulating specific genes (Bcl-2 family) shows potential for neuroprotection and preventing epilepsy development.
Area of Science:
- Neuroscience
- Molecular Biology
- Epilepsy Research
Background:
- Seizures can cause brain damage and neuronal loss, potentially leading to cognitive deficits and epilepsy.
- The Bcl-2 gene family and related proteins play critical roles in neuronal survival and apoptosis.
Purpose of the Study:
- To investigate the role of Bcl-2 family genes and other molecular targets in neuronal death during seizures.
- To explore the potential of manipulating these targets for neuroprotection and anti-epileptogenic strategies.
Main Methods:
- Utilized genetically modified mice, Tat protein transduction, and viral vectors to manipulate gene expression.
- Examined the effects of these manipulations on neuronal death in status epilepticus models.
- Analyzed hippocampal gene expression and endoplasmic reticulum stress markers in epilepsy patients.
Main Results:
- Functional effects of manipulating Bcl-2, Bcl-w, heat shock proteins, caspases, and endonucleases on neuronal death were observed.
- Ancillary effects on seizure induction and excitability thresholds were noted for several genes.
- Differing hippocampal expression of Bcl-2 family genes, elevated endoplasmic reticulum stress chaperones, and modulated death receptor pathways were found in epilepsy patients.
Conclusions:
- Targeting Bcl-2 family proteins and related pathways offers potential neuroprotective strategies against seizure-induced brain damage.
- Modulating these molecular targets may provide adjunctive therapies to prevent epilepsy development or progression.
- Findings highlight the clinical relevance of studying these molecular mechanisms in human epilepsy.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

